[Ip-health] Imatinib (Gleevec/Glivec) - International survery of prices

Peter Maybarduk pmaybarduk at citizen.org
Wed Nov 7 10:22:10 PST 2012


We are collecting prices for imatinib, used in the treatment of some cancers such as chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST). Novartis markets imatinib under the brand name Gleevec and its salt form, imatinib mesylate, under the brand name Glivec.

We would be grateful for your help in collecting data points for this survey which is of interest to people working to expand access to the drug. The results will be reported to you, once aggregated. 

If you would like to respond to the survey, please include the following information:

*Imatinib survey*

1. Brand name and generic name
2. Name of the supplier (is it marketed directly by Novartis or a different firm)
3. Specification (100 mg tablet, 400mg tablet etc.)
4. Price per unit (price per tablet, price per 100 tablets etc.) and the currency
5. Price detail:
        > is it the retail, wholesale or ex-factory price
        > for retail prices - what are the price components (margins, VAT, etc.)
6. Source:
        > country
        > public or private sector price
        > name of source - health facility, pharmacy, website etc.
7. Date on which price was collected

Please feel free to include multiple responses for prices observed through different sources and also any information regarding availability of imatinib in your country/setting.

Please reply to Peter Maybarduk:  pmaybarduk at citizen.org.

Looking forward to your input. 

Thank you, 
Peter




More information about the Ip-health mailing list